Diabetes & Vascular Disease Research

Scope & Guideline

Unraveling the complexities of diabetes and vascular disease.

Introduction

Welcome to your portal for understanding Diabetes & Vascular Disease Research, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1479-1641
PublisherSAGE PUBLICATIONS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2004 to 2024
AbbreviationDIABETES VASC DIS RE / Diabetes Vasc. Dis. Res.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The journal 'Diabetes & Vascular Disease Research' focuses on the intersection of diabetes and vascular health, emphasizing research that explores the relationships between diabetes, cardiovascular diseases, and related complications. Its scope encompasses clinical studies, epidemiological research, and molecular investigations aimed at understanding the mechanisms underlying these conditions and improving patient outcomes.
  1. Diabetes and Cardiovascular Disease Interactions:
    Researching the impact of diabetes on cardiovascular health, including the prevalence of heart disease among diabetic patients and mechanisms of cardiovascular complications.
  2. Microvascular and Macrovascular Complications:
    Exploring the pathophysiology, risk factors, and treatment approaches for complications associated with diabetes, such as diabetic nephropathy, retinopathy, and peripheral artery disease.
  3. Innovative Therapeutic Approaches:
    Investigating new medications, treatment regimens, and interventions aimed at managing diabetes and its vascular complications, including pharmacological studies and real-world applications.
  4. Epidemiological Studies:
    Conducting population-based studies to assess the incidence, prevalence, and risk factors associated with diabetes and its complications across different demographics.
  5. Biomarkers and Molecular Mechanisms:
    Identifying biomarkers and understanding the molecular pathways involved in diabetes and vascular dysfunction to facilitate early diagnosis and targeted therapy.
Recent publications in 'Diabetes & Vascular Disease Research' reveal significant trends and emerging themes that are reshaping the understanding of diabetes and its vascular implications. These themes reflect advancements in technology, evolving treatment paradigms, and a deeper understanding of disease mechanisms.
  1. Role of Novel Therapeutics:
    An increasing focus on the efficacy of novel diabetes medications, particularly sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists, in reducing cardiovascular and renal risks associated with diabetes.
  2. Microvascular Complications and Inflammation:
    Emerging research is highlighting the role of inflammation in the development of microvascular complications, such as diabetic retinopathy and nephropathy, leading to new therapeutic targets.
  3. Integration of Technology in Diabetes Management:
    The use of continuous glucose monitoring systems and digital health technologies is trending, with research exploring their impact on glycemic control and patient outcomes.
  4. Psychosocial Factors in Diabetes Management:
    There is a growing recognition of the importance of psychological and social factors in diabetes management, with studies investigating how these factors influence disease progression and treatment adherence.
  5. Longitudinal and Cohort Studies:
    A trend towards conducting longitudinal studies that track diabetes progression and its vascular complications over time, providing insights into long-term outcomes and risk factors.

Declining or Waning

While certain areas of research maintain a robust presence in the journal, others appear to be declining in frequency or relevance. This decline may suggest shifts in research priorities or advancements in understanding that make some previously emphasized topics less prominent.
  1. Historical Cardiovascular Risk Factors:
    Research focusing on traditional cardiovascular risk factors in isolation, such as cholesterol levels or hypertension, appears to be waning as studies increasingly emphasize the interconnectivity between diabetes and broader health outcomes.
  2. Basic Science Approaches without Clinical Applications:
    There seems to be a decrease in purely basic science studies that do not directly translate to clinical practice or patient outcomes, as the journal shifts towards more translational research that impacts patient care.
  3. Single-Factor Studies:
    Studies that examine the effects of diabetes on vascular health in isolation without considering the multifactorial nature of these diseases are becoming less common, reflecting a trend towards a more holistic approach in research.

Similar Journals

Journal of Diabetes Investigation

Pioneering insights for improved diabetes care.
Publisher: WILEYISSN: 2040-1116Frequency: 6 issues/year

Journal of Diabetes Investigation is a prestigious open-access journal published by WILEY, dedicated to advancing knowledge in the fields of Endocrinology, Diabetes, and Metabolism. With its ISSN 2040-1116 and E-ISSN 2040-1124, the journal provides a vital platform for researchers, healthcare professionals, and students to disseminate high-quality research, foster innovative ideas, and engage with cutting-edge developments in diabetes investigation. Since its inception in 2010, the journal has established a solid reputation, ranking in Q2 for Endocrinology and Diabetes and Metabolism, and Q1 for both Internal Medicine and Miscellaneous Medicine categories in 2023. Its Scopus rankings further underscore its impact, notably at the 76th percentile in Internal Medicine. The open access model, adopted in 2014, ensures that vital information is freely available, promoting global collaboration and knowledge sharing. The journal is not only a reflection of Australia's commitment to medical research but also a beacon for advancements that can ultimately enhance patient outcomes in diabetes care.

Journal of Cardiovascular Development and Disease

Advancing cardiovascular knowledge for a healthier tomorrow.
Publisher: MDPIISSN: Frequency: 12 issues/year

Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.

MICROVASCULAR RESEARCH

Exploring the Intricacies of Microvascular Dynamics
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0026-2862Frequency: 6 issues/year

Microvascular Research is a prominent journal dedicated to advancing the understanding of microvascular biology and its implications in various health and disease contexts. Published by Academic Press Inc elsevier Science, this journal holds a significant place in the academic community with an impact factor reflecting its high citation frequency and relevance within its fields. With a Q2 ranking in both Biochemistry and Cardiology and Cardiovascular Medicine, as well as a Q3 ranking in Cell Biology, it provides an essential platform for researchers and professionals to publish and access groundbreaking studies. Established in 1968 and running through to 2025, Microvascular Research covers a broad scope, focusing on various topics related to microvessels and their functions, emphasizing the importance of these structures in health and pathology. Although the journal does not offer open access, it remains a vital resource for those seeking to deepen their understanding of microvascular dynamics, making it an essential addition to the libraries of researchers, clinicians, and students alike.

Vascular

Exploring the frontiers of cardiology and surgery.
Publisher: SAGE PUBLICATIONS LTDISSN: 1708-5381Frequency: 6 issues/year

Vascular is a premier academic journal published by SAGE Publications Ltd, focusing on a wide range of disciplines within the fields of cardiology, cardiovascular medicine, surgery, and radiology. Established in 1993 and continuing through 2024, this journal serves as an essential resource for researchers and professionals seeking to advance their understanding of vascular health and disease. With an impressive categorization in the Q3 quartile for cardiology and cardiovascular medicine, and Q2 quartile for surgery, Vascular has established itself as a reputable platform for disseminating cutting-edge research and innovative clinical practices. The journal's positioning in various Scopus Ranks reflects its relevance and contribution to advancing these critical medical fields, making it an indispensable tool for students, clinicians, and researchers alike. For those interested in keeping abreast of the latest developments, Vascular offers a rich repository of articles that contribute significantly to the global discourse on vascular diseases.

Current Vascular Pharmacology

Unveiling Breakthroughs in Vascular Therapeutics
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1570-1611Frequency: 6 issues/year

Current Vascular Pharmacology is a premier academic journal published by Bentham Science Publications Ltd, focusing on the intersection of pharmacology and cardiovascular medicine. With an impact factor that reflects its significance in the field, this journal ranks in the Q1 category for both Pharmacology and Cardiology, showcasing its dedication to high-quality research. Its Scopus ranks place it in the top percentile of its categories, highlighting its influence among scholars and practitioners alike. Issued since 2003 and continuing through 2024, Current Vascular Pharmacology aims to disseminate cutting-edge findings and foster knowledge exchange among researchers, professionals, and students engaged in cardiovascular pharmacology. Despite being a subscription-based journal, it remains a vital resource for those seeking the latest advancements in drug development and therapeutic interventions for vascular diseases. Located in the United Arab Emirates, the journal serves as an essential platform for global discourse on vascular health.

ACTA DIABETOLOGICA

Fostering Breakthroughs in Metabolic Health
Publisher: SPRINGER-VERLAG ITALIA SRLISSN: 0940-5429Frequency: 12 issues/year

ACTA DIABETOLOGICA, published by SPRINGER-VERLAG ITALIA SRL, is a distinguished peer-reviewed journal dedicated to the rapidly evolving fields of endocrinology, diabetes, and metabolism. With an impressive convergence of research from 1991 to 2024, it is recognized for its significant contributions, boasting a Q1 ranking in Internal Medicine and Q2 rankings in Endocrinology categories as of 2023. Its Scopus rankings further highlight its impact, placing it in the 81st percentile in Internal Medicine. The journal serves as a vital platform for professionals and researchers, facilitating the dissemination of innovative findings and fostering a comprehensive understanding of metabolic disorders. Although the journal is not open access, it remains an essential resource, ensuring high visibility and accessibility of critical research to its scholarly audience.

VASCULAR MEDICINE

Advancing cardiovascular health through impactful research.
Publisher: SAGE PUBLICATIONS LTDISSN: 1358-863XFrequency: 6 issues/year

Vascular Medicine is a premier academic journal for researchers and practitioners in the field of cardiovascular health, published by SAGE Publications Ltd. With an ISSN of 1358-863X and E-ISSN 1477-0377, this esteemed journal has been at the forefront of publishing quality research since its inception in 1992, with convergence extending to 2024. Ranked in the Q2 category for both Cardiology and Cardiovascular Medicine as well as for miscellaneous Medicine in 2023, it is recognized for its significant contributions to advancing knowledge and clinical practice within these domains. Its Scopus ranking situates it at #91 out of 387 in the field, reflecting its high impact and the relevance of its published research, which is crucial for addressing the challenges in vascular health today. Although it is not an open-access journal, Vascular Medicine remains dedicated to disseminating vital findings that bridge the gap between research and clinical application, making it an essential resource for medical researchers, healthcare professionals, and students alike.

CLINICAL SCIENCE

Advancing the Frontiers of Clinical Knowledge
Publisher: PORTLAND PRESS LTDISSN: 0143-5221Frequency: 24 issues/year

CLINICAL SCIENCE, published by PORTLAND PRESS LTD, is a prestigious journal with an established history that dates back to 1946. Renowned for its rigorous peer-reviewed articles, the journal is dedicated to advancing knowledge in the field of medicine, particularly in the nuances of clinical science and translational research. With an impressive Q1 ranking in the **Medicine (miscellaneous)** category and a Scopus rank of #32 out of 636 in general medicine, it is firmly positioned in the top 5% percentile of its field, making it an essential resource for researchers, practitioners, and students aiming to stay at the forefront of the discipline. Although the journal operates on a traditional subscription model, its influence and accessibility ensure that critical findings and innovative methodologies reach a wide audience, fostering collaboration and progress within the global medical community. The journal seeks to publish groundbreaking studies, critical reviews, and insights that can translate into improved clinical practices, thus reinforcing its mission to enhance patient care and medical knowledge.

Vasa-European Journal of Vascular Medicine

Empowering Vascular Health with Cutting-Edge Scholarship
Publisher: HOGREFE AG-HOGREFE AG SUISSEISSN: 0301-1526Frequency: 6 issues/year

Vasa - European Journal of Vascular Medicine is a leading peer-reviewed journal dedicated to advancing the field of vascular medicine, published by HOGREFE AG in Switzerland. With a proud history dating back to 1972, this journal serves as a critical platform for researchers, clinicians, and healthcare professionals committed to enhancing knowledge and practice related to cardiovascular health and vascular disorders. Holding a notable Q2 ranking in the cardiology and cardiovascular medicine category, Vasa’s scholarly contributions reflect high-quality research and innovative insights that drive clinical applications. The journal provides essential access to original articles, reviews, and case studies, fostering a vibrant exchange of ideas within the vascular medicine community. Its Scopus rank of #159 out of 387 further underscores its impact, placing it confidently in the 59th percentile among its peers. Vasa is synonymous with rigorous academic standards and relevance, making it an invaluable resource for anyone seeking to stay at the forefront of vascular research and its clinical implications.

Clinical Medicine Insights-Cardiology

Advancing Knowledge in Cardiology for a Healthier Future
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5468Frequency: 1 issue/year

Clinical Medicine Insights-Cardiology is a prestigious open-access journal published by SAGE Publications Ltd, focusing on cutting-edge research in the field of cardiology and cardiovascular medicine. With the ever-evolving landscape of cardiovascular health, this journal serves as a vital platform for disseminating significant findings, clinical practices, and innovative therapies. Established in 2007, it has rapidly gained recognition, currently ranked in the Q2 category for cardiology, positioned at #112 out of 387 in Scopus Rankings, and boasting a commendable 71st percentile. The journal not only emphasizes the integration of recent advancements in clinical and laboratory studies but also aims to bridge the gap between research and practice, making it an essential resource for researchers, healthcare professionals, and students alike. Situated in New Zealand and operating with an open-access model, Clinical Medicine Insights-Cardiology promotes the unrestricted dissemination of knowledge, ensuring that critical insights into cardiovascular medicine are accessible globally.